- Roche Hemophilia Drug Lowers Costs Despite High Price: ICER Managed Care magazine
- Europe: thumbs up for Roche's Hemlibra, Chiesi rare disease drug, bad news for Santhera pharmaphorum
- Seven medicines leap closer to EU approval PharmaTimesFull coverage
|
No comments:
Post a Comment